Want to join the conversation?
$CBM agreed to buy privately-owned PharmaCore, which specializes in developing, manufacturing and scaling up small molecule Active Pharmaceutical Ingredients (APIs) for clinical phase projects, for about $25MM. $CBM expects deal, net of deal fees, to have neutral impact on EPS in 2016 and to be accretive in 2017. The deal will close within 30 days.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!